Oncocyte logo

Oncocyte share price today

(OCX)

Oncocyte share price is $2.38 & ₹203.85 as on 1 Jan 2025, 2.30 'hrs' IST

$2.38

-0.07

(-2.86%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Oncocyte share price in Dollar and Rupees. Guide to invest in Oncocyte from India. Also see the sentimental analysis on Indian investors investing in Oncocyte. Get details on the Indian mutual funds that are investing in Oncocyte. Get Analyst recommendations and forecasts along with all the Oncocyte's financials.

Oncocyte share price movements

  • Today's Low: $2.33
    Today's High: $2.60

    Day's Volatility :10.54%

  • 52 Weeks Low: $1.97
    52 Weeks High: $3.82

    52 Weeks Volatility :48.43%

Oncocyte Returns

PeriodOncocyte CorpSector (Health Care)Index (Russel 2000)
3 Months
-20.13%
-10.0%
0.0%
6 Months
-21.45%
-4.7%
0.0%
1 Year
-33.89%
-0.9%
0.0%
3 Years
-94.71%
-2.4%
-21.2%

Oncocyte Key Statistics

in dollars & INR

Previous Close
$2.45
Open
$2.52
Today's High
$2.601
Today's Low
$2.3268
Market Capitalization
$40.1M
Today's Volume
$47.4K
52 Week High
$3.82
52 Week Low
$1.97
Revenue TTM
$709.0K
EBITDA
$-21.6M
Earnings Per Share (EPS)
$-4.44
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-165.32%

How to invest in Oncocyte from India?

It is very easy for Indian residents to invest directly in Oncocyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncocyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncocyte or OCX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncocyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncocyte shares which would translate to 0.360 fractional shares of Oncocyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncocyte, in just a few clicks!

Returns in Oncocyte for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oncocyte investment value today

Current value as on today

₹68,978

Returns

₹31,022

(-31.02%)

Returns from Oncocyte Stock

₹33,889 (-33.89%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Oncocyte

109%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Oncocyte on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 109% more investors are searching Oncocyte in the last 30 days versus the previous period.

Global Institutional Holdings in Oncocyte

  • BROADWOOD CAPITAL Inc

    29.28%

  • Awm Investment Company Inc

    6.52%

  • PURA VIDA INVESTMENTS, LLC

    2.94%

  • Vanguard Group Inc

    1.46%

  • Geode Capital Management, LLC

    0.62%

  • BlackRock Inc

    0.43%

Analyst Recommendation on Oncocyte

Buy

    62%Buy

    37%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Oncocyte(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
4
5
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Oncocyte

What analysts predicted

Upside of 73.32%

Current:

$2.38

Target:

$4.13

Insights on Oncocyte

  • Price Movement

    In the last 7 days, OCX stock has moved up by 11.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 104.0K → 115.0K (in $), with an average increase of 9.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -4.53M → -13.49M (in $), with an average decrease of 197.9% per quarter
  • OCX vs DHR (1 yr)

    In the last 1 year, Oncocyte Corp has experienced a drawdown of -27.9%, however Danaher Corp. resisted the overall trend and outperformed by 25.7%
  • OCX vs A (3 yr)

    In the last 3 years, Oncocyte Corp has experienced a drawdown of -94.5%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 64.3%
  • Price to Sales

    ForOCX every $1 of sales, investors are willing to pay $36.1, whereas for Danaher Corp., the investors are paying $7.1 for every $1 of sales.

Oncocyte Technicals Summary

Sell

Neutral

Buy

Oncocyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Oncocyte Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oncocyte Corp
-1.04%
-21.45%
-33.89%
-94.71%
-95.2%
Idexx Laboratories, Inc.
-4.32%
-14.93%
-22.73%
-34.48%
54.89%
Agilent Technologies Inc.
-3.55%
6.31%
2.42%
-14.15%
58.38%
Thermo Fisher Scientific, Inc.
-2.66%
-3.68%
-1.62%
-19.33%
60.0%
Danaher Corp.
-4.7%
-4.05%
-0.55%
-27.3%
48.47%
Iqvia Holdings Inc.
-2.03%
-5.57%
-10.68%
-28.17%
26.78%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oncocyte Corp
NA
NA
0.0
0.0
-1.65
-0.19
NA
0.71
Idexx Laboratories, Inc.
39.83
39.83
4.34
10.73
0.59
0.23
NA
19.72
Agilent Technologies Inc.
30.33
30.33
2.28
5.56
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
32.58
32.58
1.98
21.7
0.13
0.05
0.0
128.08
Danaher Corp.
43.31
43.31
3.07
7.5
0.08
0.04
0.0
71.03
Iqvia Holdings Inc.
25.86
25.86
1.04
11.11
0.22
0.05
NA
38.37
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oncocyte Corp
Buy
$40.1M
-95.2%
NA
0.0%
Idexx Laboratories, Inc.
Buy
$33.9B
54.89%
39.83
22.53%
Agilent Technologies Inc.
Buy
$38.4B
58.38%
30.33
21.75%
Thermo Fisher Scientific, Inc.
Buy
$199.0B
60.0%
32.58
14.48%
Danaher Corp.
Buy
$165.8B
48.47%
43.31
16.39%
Iqvia Holdings Inc.
Buy
$35.7B
26.78%
25.86
9.17%

About Oncocyte

oncocyte is focused on the discovery, development, and commercialization of non-invasive, liquid biopsy diagnostics to facilitate clinical decision making in the early detection of cancer. the company's pipeline is focused on molecular tests for areas of high unmet need - lung, breast, and bladder cancers - where the current standard of diagnostic care is often ambiguous, costly, and involves invasive surgical procedures. oncocyte's diagnostics are developed based on a proprietary set of biomarkers that have been shown to differentiate benign from malignant nodules or masses. for more information, visit www.oncocyte.com.
Organization
Oncocyte
Employees
43
CEO
Mr. Joshua Riggs
Industry
Health Technology

Management People of Oncocyte

NameTitle
Mr. Joshua Riggs
President, CEO & Director
Mr. James Liu
Senior Director, Controller & Principal Accounting Officer
Dr. Ekkehard Schutz M.D., Ph.D.
Chief Science Officer
Ms. Andrea Susan James
Chief Financial Officer
Mr. Yuh-Min Chiang Ph.D.
Chief Technology Officer
Mr. Peter Hong
VP, General Counsel & Secretary
Ms. Sandra O'Donald
Senior Vice President of Business Operations
Dr. Michael D. West Ph.D.
Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

Important FAQs about investing in Oncocyte from India :

What is Oncocyte share price today?

Oncocyte share price today stands at $2.38, Open: $2.52 ; Previous Close: $2.45 ; High: $2.60 ; Low: $2.33 ; 52 Week High: $3.82 ; 52 Week Low: $1.97. The stock opens at $2.52, after a previous close of $2.45. The stock reached a daily high of $2.60 and a low of $2.33, with a 52-week high of $3.82 and a 52-week low of $1.97.

Can Indians buy Oncocyte shares?

Yes, Indians can invest in the Oncocyte (OCX) from India.

With INDmoney, you can buy Oncocyte at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oncocyte at zero transaction cost.

How can I buy Oncocyte shares from India?

It is very easy to buy Oncocyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncocyte be purchased?

Yes, you can buy fractional shares of Oncocyte with INDmoney app.

What are the documents required to start investing in Oncocyte stocks?

To start investing in Oncocyte, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oncocyte

Today’s highest price of Oncocyte (OCX) is $2.60.

Today’s lowest price of Oncocyte (OCX) is $2.33.

What is today's market capitalisation of Oncocyte

Today's market capitalisation of Oncocyte OCX is 40.1M

What is the 52 Week High and Low Range of Oncocyte

  • 52 Week High

    $3.82

  • 52 Week Low

    $1.97

What are the historical returns of Oncocyte?

  • 1 Month Returns

    -1.04%

  • 3 Months Returns

    -21.45%

  • 1 Year Returns

    -33.89%

  • 5 Years Returns

    -95.2%

Who is the Chief Executive Officer (CEO) of Oncocyte

Mr. Joshua Riggs is the current Chief Executive Officer (CEO) of Oncocyte.